Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arch Therapeutics Inc (OTCQB:ARTH)

0.5799
Delayed Data
As of 3:59pm ET
 -0.0096 / -1.63%
Today’s Change
0.41
Today|||52-Week Range
0.89
-0.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$90.7M

Company Description

Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development of novel approach to stop bleeding, control leaking, and manage wounds during surgery, trauma, and interventional care. Its products candidates include AC5 Devices. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.

Contact Information

Arch Therapeutics, Inc.
235 Walnut Street
Framingham Massachusetts 01702
P:(617) 431-2313
Investor Relations:

Employees

Shareholders

Individual stakeholders14.85%
Mutual fund holders--
Other institutional--

Top Executives

Terrence W. NorchiPresident, Chief Executive Officer & Director
Richard E. DavisChief Financial Officer & Treasurer
Steven A. KatesVice President-Technology
Chirag ShahVice President-Research & Development Engineering
Jayne PratsVice President-Medical & Technical Marketing